
Eli Lilly changes outcome goals in Alzheimer's drug study
by Linda A. JohnsonEli Lilly said Tuesday that it's changed the outcome goals for a late-stage patient study of its closely watched experimental drug for Alzheimer's disease, solanezumab.The E
Updated on: February 28,2024
13

Eli Lilly changes outcome goals in Alzheimer's drug study
by Linda A. JohnsonEli Lilly said Tuesday that it's changed the outcome goals for a late-stage patient study of its closely watched experimental drug for Alzheimer's disease, solanezumab.The E
Updated on:February 28,2024
13
